Guotai Healthcare Files IPO Prospectus: Empowering Over 5.6 Million Medical Professionals with AI-Driven Digital Health Solutions
One day in September, with a cloudless sky over Beijing, sunlight crept onto the desk on the 8th floor of Zhongqing Building at No. 10A Dewai Street, Xicheng District, where Gao Zhan was buried in work, completely unaware.
A map of China was posted on the wall behind him, with red markers covering most of its area, drawing immediate attention. “These are the ‘strongholds’ captured by the ‘Good Doctor’ brand under Guotai Medical,” Chairman Gao Zhan told VCBeat, a slight smile playing on his lips.
Not only that, Gao Zhan also recited with great familiarity the achievements of Guotai Medical over the past 18 years: covering more than 66% of healthcare professionals across China, 90% of Tier II and Tier III hospitals, and over 2,000 health commissions nationwide, with annual paying users exceeding one million...
Physicians are the core of healthcare, spanning patient diagnosis and treatment, medication management, and payment cost control. The healthcare reform process requires the application of various tools to empower physicians. As healthcare reform focuses on improving the quality of medical services, promoting the decentralization of medical resources to primary care levels, and rectifying abnormal business models, it has created a new market demand for precise physician empowerment solutions valued at nearly RMB 50 billion. For eighteen years, Guotai Medical has been dedicated to providing physician services, with its client base covering 90% of hospitals and physicians across China. It continuously improves, enhances, and expands its product line of physician empowerment tools in response to their evolving needs.
“Our business logic is to empower good doctors with technology, shaping our commercial strategy around their professional needs: one aspect is continuously empowering doctors to enhance their skills and improve the quality of medical services; the other is collaborating with leading pharmaceutical companies to equip doctors with the latest technologies and products for better patient outcomes. By empowering good doctors through technology, we ultimately benefit patients and contribute to healthier communities,” CEO Hua Wei told reporters.
The company’s “Hao Yisheng” brand has been dedicated to online continuing medical education services for physicians for over 18 years, covering 66% of healthcare professionals across China. Its grassroots smart healthcare products reach 15% of China’s county-level regions. With access to the most authoritative expert and physician resources, it is one of the largest online platforms for physicians and grassroots healthcare services in China.
For a long time, China’s healthcare industry has faced multiple pain points among patients and doctors, physicians, hospitals, and pharmaceutical companies. Healthcare is a multi-stakeholder industry. As healthcare reform enters a deeper phase, physicians require more precise empowerment tools. For example, Dr. Hao, Chief Physician of Pediatrics at a county hospital in Hebei Province, seeks to enhance his clinical skills by collaborating with top domestic experts in pediatric upper respiratory tract infections, partnering with enterprises offering the latest technologies and products across China, providing patients with better diagnosis and treatment, and keeping pace with leading domestic and even international standards. Leveraging its network of one million physicians accumulated over nearly 20 years in the healthcare industry, Guotai Medical has continuously upgraded and expanded its portfolio of precise physician empowerment solutions, positioning itself at the forefront of the industry.
Guotai Medical, centered on 5.6 million healthcare professionals, leverages big data and artificial intelligence innovations to provide smart healthcare platforms and precision physician empowerment product lines, delivering comprehensive services to China’s healthcare industry.
Starting with education and training, Guotai is the first comprehensive internet platform in China approved by the National Health Commission to conduct remote continuing medical education (CME) via the internet. With 5.6 million professional medical members, it serves over 3 million healthcare professionals annually through the Haoyisheng website for CME training. As the largest CME institution in China, it organizes more than 10,000 CME projects covering all tertiary disciplines, along with over 100 general or specialized training programs spanning areas such as laws and regulations, medical humanities, and infectious diseases.
Meanwhile, the company operates the largest medical professional information service website in the Chinese language. Its central hardware and software products currently serve over 20,000 medical institutions, making it the IT and service provider with the broadest coverage in China’s healthcare industry. With the implementation of the national “Internet+” healthcare policy, Guotai Medical is committed to providing an online diagnosis and treatment platform for 66% of healthcare workers across China through its “Internet+ Physician Training” and “Internet+ Primary Care” initiatives. Its smart healthcare products cover 15% of county-level regions nationwide, serving an average of 300,000 patients daily and managing 50 million resident health records. The company boasts 5.6 million website members, 1.2 million WeChat subscribers, and 850,000 real-name verified physician users on its app, with WeChat articles regularly achieving over 100,000 views, establishing it as one of the most widely covering professional empowerment platforms for physicians in China.
It is reported that over the past three years, the company has devoted substantial efforts to enhancing its products to meet the needs of physicians throughout their entire careers, upgrading them into comprehensive solutions for precise physician empowerment. For instance, through strategic collaborations with top-tier overseas medical institutions and associations—including Harvard Medical School, Mayo Clinic, the Chinese American Medical Association (CAMA), Cambridge University Hospitals, Heidelberg University Hospital, and the Royal College of Physicians of the United Kingdom—the company has established a precision training platform serving physicians and hospitals at all levels. This platform facilitates engagement not only with domestic institutions but also with world-class medical schools and hospitals internationally. Its business operations now cover major medically advanced countries, including the United States, the United Kingdom, Italy, Germany, Australia, Canada, Japan, and South Korea.
In line with the national initiative to promote “Internet + Healthcare,” the company has developed a domestically leading digital hospital and internet hospital system. For instance, by establishing an internet hospital platform for Chengfei Hospital, it empowers its team of experts and physicians to leverage smart healthcare tools, thereby extending their reach and delivering higher-quality services to patients across Chengdu and Sichuan Province.
To address the specialized academic promotion needs of pharmaceutical products, leveraging the company’s 18-year foundation in physician education and training, we utilize China’s leading big data profiling of physicians to precisely target each doctor’s academic and clinical needs. By personally matching pharmaceutical products and employing AI technology, we assist pharmaceutical companies in promoting new technologies at the grassroots level through Guotai Medical’s comprehensive online, offline, and smart healthcare channels.
With a core philosophy of “Good Doctors,” the company is optimistic about the future of big data and AI applications. Hua Wei believes that in the current era of collaborative healthcare, market demand falls into two categories: one is primary care, which is bound to boom in the future; the other is technology-enabled healthcare, specifically the practical implementation of technologies such as big data and AI.
Leveraging eighteen years of accumulation, Guotai Medical has secured China’s most authoritative academic resources for continuing medical education, comprehensive data on healthcare human resources, and a suite of medical service-related businesses and product lines. Building on this foundation, Haoyisheng Big Data has assembled high-quality interdisciplinary research talent to conduct scenario-based research and targeted applications of internet and artificial intelligence (AI) technologies in the healthcare sector. By integrating AI technology into its existing collaborative healthcare systems, the company maximizes empowerment for physicians, fostering a smart healthcare ecosystem within a scientific framework of “Internet + AI.”
This September, Guotai Medical, in collaboration with Tsinghua University, the China Health Promotion Association, Beijing Tongren Hospital, Fudan University, Tongji University, The First Affiliated Hospital of Sun Yat-sen University, the Development Research Center of the National Health Commission, iFlytek, and Xunzheng, successfully stood out from dozens of leading competitors in the medical AI sector. Their joint application for a National Major Special Project on Medical AI was selected, making them one of only three institutions nationwide to receive support from the Ministry of Science and Technology.
Leveraging big data application technologies for physicians, Guotai Medical has established a platform and business model that facilitates resource sharing. “We are an open platform. The core products of our Big Data R&D Center currently include Intelligent Data, Intelligent Assistant, Intelligent Education, and Smart Healthcare. We provide the largest and most comprehensive intelligent management platform for physician big data in China, along with related precision big data services. We welcome partners in the healthcare industry to join us in better empowering physicians.”
Guided by its vision of “Empowering Good Doctors with Technology,” Guotai Medical leverages big data applications to address market demands within the broader context of healthcare reform, driven by its dual-core service model. “Our business volume doubled this year compared to last year,” added Hua Wei.